Participants to learn more about the importance of clinical research trials
Beaumont’s Cancer Institute is committed to cancer prevention counseling, detection and treatment, including localizing cancer care research and delivery in community settings. Metro Detroit area residents with cancer now have access to federally-funded cancer research studies thanks to a five-year grant recently awarded to Beaumont. Beaumont Health System is one of 34 community sites participating in the National Cancer Institute’s Community Oncology Research Program, also known as NCORP.
On Thursday, Sept. 11, from 5:30 to 9 p.m., Beaumont Health System is hosting an evening awareness program for patients and families at the Troy Marriott, 200 West Big Beaver Road. The program, which includes dinner and a panel of experts on breast and ovarian cancer, will emphasize the importance of area clinical research trials.
Along with an overview on clinical trials, panelist Dana Zakalik, M.D., corporate director, Beaumont Cancer Genetics Program will discuss family history and genetics.
Explains Dr. Zakalik, “Genetic mutations are risk factors for both breast and ovarian cancer. Testing can help determine a person’s risk for developing certain cancers. Identifying cancer genes, the presence of BRCA 1 and 2 mutations, is the first step. This testing allows the implementation of risk-reducing interventions: more frequent screening, surgical prevention and chemoprevention. For patients and families at risk for hereditary breast and ovarian cancer due to BRCA mutations or other genes, the information gained from genetic testing can provide answers.”
The program also includes a health fair with exhibits and presentations addressing:
- Integrative Medicine
- Support groups
- American Cancer Society Clinical Trial Matching Service
While there are no fees to attend the event, registration is required. Space is limited. Please register by Sept. 5. To register, call 800-633-7377 or go online at http://classes.beaumont.edu/. Dinner will be provided.
# # #
About Beaumont’s Cancer Program
Beaumont’s comprehensive cancer program combines the expertise of surgical, medical and radiation oncologists to offer cancer prevention counseling, diagnosis and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 34 community sites in the U.S. to be awarded a five-year National Cancer Institute Community Oncology Research Program grant. Beaumont is designated as a Blue Cross Center of Distinction for the Treatment of Rare and Complex Cancers. Beaumont, Royal Oak and Troy are recognized by U.S. News & World Report as “high performing” hospitals for cancer care. Find out more at http://cancer.beaumont.edu/.